JPMorgan Chase & Co’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$126M Sell
1,002,502
-461,218
-32% -$57.9M 0.01% 774
2025
Q1
$200M Sell
1,463,720
-632,594
-30% -$86.6M 0.01% 633
2024
Q4
$321M Sell
2,096,314
-3,161,009
-60% -$483M 0.02% 474
2024
Q3
$1.02B Buy
5,257,323
+542,366
+12% +$105M 0.08% 222
2024
Q2
$1.09B Sell
4,714,957
-5,187
-0.1% -$1.2M 0.09% 203
2024
Q1
$1.02B Sell
4,720,144
-352,496
-7% -$76M 0.09% 218
2023
Q4
$1.31B Buy
5,072,640
+86,888
+2% +$22.5M 0.13% 153
2023
Q3
$1.28B Buy
4,985,752
+514,565
+12% +$132M 0.14% 139
2023
Q2
$1.27B Buy
4,471,187
+362,324
+9% +$103M 0.14% 150
2023
Q1
$1.14B Buy
4,108,863
+1,838,556
+81% +$511M 0.14% 152
2022
Q4
$629M Buy
2,270,307
+166,390
+8% +$46.1M 0.08% 227
2022
Q3
$562M Buy
2,103,917
+128,827
+7% +$34.4M 0.08% 234
2022
Q2
$403M Sell
1,975,090
-200,467
-9% -$40.9M 0.06% 304
2022
Q1
$458M Sell
2,175,557
-2,360,923
-52% -$497M 0.06% 309
2021
Q4
$1.09B Sell
4,536,480
-1,068,817
-19% -$256M 0.13% 169
2021
Q3
$1.59B Buy
5,605,297
+250,531
+5% +$70.9M 0.2% 112
2021
Q2
$1.85B Buy
5,354,766
+1,467,865
+38% +$508M 0.22% 93
2021
Q1
$1.09B Buy
3,886,901
+974,880
+33% +$273M 0.15% 150
2020
Q4
$713M Buy
2,912,021
+838,296
+40% +$205M 0.1% 192
2020
Q3
$586M Buy
2,073,725
+88,010
+4% +$24.8M 0.1% 194
2020
Q2
$531M Buy
1,985,715
+528,920
+36% +$142M 0.1% 200
2020
Q1
$461M Buy
1,456,795
+16,971
+1% +$5.37M 0.11% 185
2019
Q4
$427M Buy
1,439,824
+510,618
+55% +$152M 0.08% 247
2019
Q3
$216M Sell
929,206
-29,901
-3% -$6.96M 0.04% 394
2019
Q2
$230M Sell
959,107
-828,233
-46% -$199M 0.05% 387
2019
Q1
$422M Sell
1,787,340
-880,495
-33% -$208M 0.09% 241
2018
Q4
$803M Sell
2,667,835
-141,554
-5% -$42.6M 0.19% 118
2018
Q3
$993M Buy
2,809,389
+246,886
+10% +$87.2M 0.19% 108
2018
Q2
$744M Sell
2,562,503
-508,348
-17% -$148M 0.15% 129
2018
Q1
$841M Buy
3,070,851
+254,334
+9% +$69.6M 0.18% 124
2017
Q4
$897M Buy
2,816,517
+331,988
+13% +$106M 0.19% 110
2017
Q3
$770M Buy
2,484,529
+208,228
+9% +$64.6M 0.17% 121
2017
Q2
$618M Sell
2,276,301
-1,341,260
-37% -$364M 0.14% 149
2017
Q1
$989M Sell
3,617,561
-18,118
-0.5% -$4.95M 0.23% 85
2016
Q4
$1.03B Buy
3,635,679
+21,207
+0.6% +$6.01M 0.25% 82
2016
Q3
$1.13B Buy
3,614,472
+518,928
+17% +$162M 0.28% 69
2016
Q2
$749M Sell
3,095,544
-689,683
-18% -$167M 0.19% 115
2016
Q1
$985M Sell
3,785,227
-519,265
-12% -$135M 0.25% 78
2015
Q4
$1.32B Buy
4,304,492
+357,790
+9% +$110M 0.33% 55
2015
Q3
$1.15B Sell
3,946,702
-1,013,729
-20% -$296M 0.31% 59
2015
Q2
$2B Sell
4,960,431
-892,604
-15% -$361M 0.47% 34
2015
Q1
$2.47B Sell
5,853,035
-1,121,931
-16% -$474M 0.56% 22
2014
Q4
$2.37B Buy
6,974,966
+51,993
+0.8% +$17.6M 0.54% 24
2014
Q3
$2.29B Sell
6,922,973
-192,080
-3% -$63.5M 0.54% 27
2014
Q2
$2.24B Buy
7,115,053
+930,103
+15% +$293M 0.57% 26
2014
Q1
$1.89B Sell
6,184,950
-688,303
-10% -$211M 0.52% 27
2013
Q4
$1.92B Sell
6,873,253
-1,905,162
-22% -$533M 0.55% 27
2013
Q3
$2.11B Sell
8,778,415
-1,009,627
-10% -$243M 0.63% 20
2013
Q2
$2.11B Buy
+9,788,042
New +$2.11B 0.67% 18